PPBT

Purple Biotech
PPBT

Overview Fund Activity

9 hedge funds and large institutions have $651K invested in Purple Biotech in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Deutsche Bank
Deutsche Bank
Germany
+$195K
2
MC
Menta Capital
California
+$158K
3
Creative Planning
Creative Planning
Kansas
+$27K
4
AG
Advisor Group
Arizona
+$26K
5
FMA
FNY Managed Accounts
New York
+$17.4K

Top Sellers

1
SM
Sabby Management
Florida
-$725K
2
Citadel Advisors
Citadel Advisors
Florida
-$80K
3
FAAS
First Allied Advisory Services
California
-$46K
4
UBS Group
UBS Group
Switzerland
-$8K
Name Holding Trade Value Shares
Change 		Shares
Change %
MC
1
Menta Capital
California
$214K +$158K +227 +284%
Deutsche Bank
2
Deutsche Bank
Germany
$195K +$195K +282 New
VKH
3
Virtu KCG Holdings
New York
$115K +$11.8K +17 +11%
Jane Street
4
Jane Street
New York
$49K +$9.66K +14 +25%
Creative Planning
5
Creative Planning
Kansas
$27K +$27K +39 New
AG
6
Advisor Group
Arizona
$26K +$26K +38 New
FMA
7
FNY Managed Accounts
New York
$17.4K +$17.4K +25 New
Wells Fargo
8
Wells Fargo
California
$7K +$2.1K +3 +43%
TRCT
9
Tower Research Capital (TRC)
New York
$1K – – –
SM
10
Sabby Management
Florida
– -$725K -1,163 Closed
Citadel Advisors
11
Citadel Advisors
Florida
– -$80K -129 Closed
FAAS
12
First Allied Advisory Services
California
– -$46K -75 Closed
UBS Group
13
UBS Group
Switzerland
– -$8K -13 Closed